From April 1, 2022 to June 30, 2022, the company has repurchased 175,000 shares, representing 0.07% for CNY 28.94 million. With this, the company has completed the repurchase of 500,000 shares, representing 0.2% for CNY 113.76 million under the buyback announced on January 23, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.75 HKD | +2.84% | +15.57% | -7.64% |
Apr. 29 | CanSino Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 22 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.64% | 1.18B | |
-3.79% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-9.12% | 11.97B | |
-14.38% | 12.07B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- Tranche Update on CanSino Biologics Inc.'s Equity Buyback Plan announced on January 23, 2022.